CLEVELAND--(BUSINESS WIRE)--Arteriocyte, Inc. and DW Healthcare Partners today announced the formation of Arteriocyte Medical Systems, Inc., launching the company with a $10 million growth capital investment. Building on Arteriocyte’s stem cell therapy platform, the new company will develop and market novel medical products to improve patient outcomes in cardiac, orthopedic and vascular surgeries; in addition, the new company will acquire market-leading products that have significant growth potential beyond their current use.
